Manhattan Eye, Ear, & Throat Hospital

New York, New York 10065

2 studies enrolling now · 15 studies all time

What they study most

Age-Related Macular Degeneration, Age-Related Macular Degenerations., Central Retinal Vein Occlusion, Chronic Central Serous Chorioretinopathy, Chronic Inflammation, Coat's Disease, Diabetic Retinopathy, Eye Diseases, Eye Injuries, Idiopathic Perifoveal Telangiectasia, Infectious Diseases, Macular Degeneration

Studies at this site

• A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma — Recruiting now
• Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness — Starting soon
• A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole — Completed
• Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg) — Completed
• Treatment of Age-Related Macular Degeneration With Anecortave Acetate — Completed
• Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) — Completed
• Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.) — Completed
• Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.) — Withdrawn before enrolling
• Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.). — Completed
• Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) — Completed
• Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration — Completed
• Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) — Stopped early
• Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg) — Stopped early
• Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). — Stopped early
• Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. — Completed